» Articles » PMID: 35326858

Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2

Overview
Specialty Pharmacology
Date 2022 Mar 25
PMID 35326858
Authors
Affiliations
Soon will be listed here.
Abstract

Carbapenems are important antibacterials and are both substrates and inhibitors of some β-lactamases. We report studies on the reaction of the unusual carbapenem biapenem, with the subclass B1 metallo-β-lactamases VIM-1 and VIM-2 and the class A serine-β-lactamase KPC-2. X-ray diffraction studies with VIM-2 crystals treated with biapenem reveal the opening of the β-lactam ring to form a mixture of the (2)-imine and enamine complexed at the active site. NMR studies on the reactions of biapenem with VIM-1, VIM-2, and KPC-2 reveal the formation of hydrolysed enamine and (2)- and (2)-imine products. The combined results support the proposal that SBL/MBL-mediated carbapenem hydrolysis results in a mixture of tautomerizing enamine and (2)- and (2)-imine products, with the thermodynamically favoured (2)-imine being the major observed species over a relatively long-time scale. The results suggest that prolonging the lifetimes of β-lactamase carbapenem complexes by optimising tautomerisation of the nascently formed enamine to the (2)-imine and likely more stable (2)-imine tautomer is of interest in developing improved carbapenems.

Citing Articles

Small-molecule inhibitors of bacterial-producing metallo-β-lactamases: insights into their resistance mechanisms and biochemical analyses of their activities.

Ayipo Y, Chong C, Mordi M RSC Med Chem. 2023; 14(6):1012-1048.

PMID: 37360393 PMC: 10285742. DOI: 10.1039/d3md00036b.


Time-resolved β-lactam cleavage by L1 metallo-β-lactamase.

Wilamowski M, Sherrell D, Kim Y, Lavens A, Henning R, Lazarski K Nat Commun. 2022; 13(1):7379.

PMID: 36450742 PMC: 9712583. DOI: 10.1038/s41467-022-35029-3.


Are the Newer Carbapenems of Any Value against Tuberculosis.

Gonzalo X, Drobniewski F Antibiotics (Basel). 2022; 11(8).

PMID: 36009939 PMC: 9404707. DOI: 10.3390/antibiotics11081070.

References
1.
Mehta S, Furey I, Pemberton O, Boragine D, Chen Y, Palzkill T . KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate. J Biol Chem. 2020; 296:100155. PMC: 7895804. DOI: 10.1074/jbc.RA120.015050. View

2.
Yamada M, Watanabe T, Baba N, Takeuchi Y, Ohsawa F, Gomi S . Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae. Antimicrob Agents Chemother. 2008; 52(6):2053-60. PMC: 2415762. DOI: 10.1128/AAC.01456-07. View

3.
Davies D, Leiris S, Sprynski N, Castandet J, Lozano C, Bousquet J . ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing . ACS Infect Dis. 2020; 6(9):2419-2430. DOI: 10.1021/acsinfecdis.0c00207. View

4.
Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis L . Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother. 2000; 46(6):1041-2. DOI: 10.1093/jac/46.6.1041. View

5.
Aertker K, Chan H, Lohans C, Schofield C . Analysis of β-lactone formation by clinically observed carbapenemases informs on a novel antibiotic resistance mechanism. J Biol Chem. 2020; 295(49):16604-16613. PMC: 7864059. DOI: 10.1074/jbc.RA120.014607. View